Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA)
| 14.07 Delayed Data As of May 26 |  +0.30 / +2.18%Today’s Change | 7.36 Today|||52-Week Range 17.20 | -6.07% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Paolini John F Chief Medical Officer |  Sale | 11/07/2022 | 28,357 | $15.18 | $430.5K | -7.68% |
Paolini John F Chief Medical Officer |  Buy | 11/07/2022 | 28,357 | $1.86 | $52.7K | -7.68% |
Patel Sanj K Chairman & Chief Executive Officer | Sale | 3/20/2023 | 3,523 | $11.12 | $39.2K | +26.53% |
Patel Sanj K Chairman & Chief Executive Officer | Sale | 4/10/2023 | 2,933 | $10.71 | $31.4K | +30.28% |
Patel Sanj K Chairman & Chief Executive Officer | Sale | 3/16/2023 | 1,929 | $11.46 | $22.1K | +22.77% |
Patel Sanj K Chairman & Chief Executive Officer | Sale | 9/02/2022 | 1,929 | $11.44 | $22.1K | +22.99% |
Moat Ross Chief Commercial Officer | Gift | 1/15/2023 | 1,844 | $9.56 | $17.6K | -2.43% |
Moat Ross Chief Commercial Officer | Sale | 4/10/2023 | 1,353 | $10.71 | $14.5K | +30.28% |
Moat Ross Chief Commercial Officer | Sale | 3/20/2023 | 1,167 | $11.12 | $13.0K | +26.53% |
Megna Michael R Chief Accounting Officer | Sale | 4/10/2023 | 1,155 | $10.71 | $12.4K | +30.28% |
Page of 6